Hospital Bellvitge

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Aortic stenosis1 trial
• Chronic spontaneous urticaria1 trial
• COPD1 trial

Phase

• Phase 22 trials

Status

• Completed3 trials

Lead sponsor

• Celldex Therapeutics1 trial
• Institut für Pharmakologie und Präventive Medizin1 trial
• Palobiofarma SL1 trial

Closed trials

• Completed

  A Phase 2 Study of CDX-0159 in Patients With Chronic Spontaneous Urticaria

  NCT05368285· Phase 2· Celldex Therapeutics· Source

• Completed

  Therapeutic Effect of PBF-680 in Patients With COPD

  NCT05262218· Phase 2· Palobiofarma SL· Source

• Completed

  Setting a Benchmark for Resource Utilization and Quality of Care in Patients Undergoing TAVI in Europe

  NCT04579445· Institut für Pharmakologie und Präventive Medizin· Source